Patrick J. Donegan - 30 Sep 2024 Form 4 Insider Report for Beneficient (BENF)

Role
Director
Signature
By: /s/ David B. Rost, Attorney-in-fact for Patrick J. Donegan
Issuer symbol
BENF
Transactions as of
30 Sep 2024
Net transactions value
$0
Form type
4
Filing time
02 Oct 2024, 19:52:31 UTC

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BENF Class A Common Stock Award $0 +138,212 $0.000000 138,212 30 Sep 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BENF Stock Option (Right to Buy) Award $0 +100,000 $0.000000 100,000 30 Sep 2024 Class A Common Stock 100,000 $1.23 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 138,212 shares of Class A common stock, par value $0.001 ("Class A common stock"), of Beneficient (the "Issuer") issuable upon the settlement of an award of 138,212 restricted stock units ("RSUs") granted pursuant to the Beneficient 2023 Equity Incentive Plan ("2023 Equity Incentive Plan") to Patrick J. Donegan (the "Reporting Person") on September 30, 2024. Such award of RSUs to the Reporting Person will vest in four equal installments on the last day of each calendar quarter over a one-year period from the date of grant, provided that the Reporting Person is providing services to the Issuer through each applicable vesting date.
F2 The shares underlying this stock option were granted pursuant to the 2023 Equity Incentive Plan and will vest and become exercisable in eight equal installments on the last day of each calendar quarter over a two-year period from the date of grant, provided that the Reporting Person is providing services to the Issuer through each applicable vesting date.